- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT04296877
Evaluation of Wear Experience With a Daily Disposable Contact Lens
March 3, 2023 updated by: Jennifer Fogt, Ohio State University
Evaluation of Wear Experience With PRECISION1® Contact Lenses in Previous Acuvue® Oasys® Lens Wearers
To evaluate the wear experience of current two-week contact lens wearers after they have been fit into a daily disposable contact lens.
This is a single arm, non-comparative study.
Study Overview
Status
Completed
Conditions
Intervention / Treatment
Detailed Description
This is a single arm, non-comparative study.
All participants were habitual lens wearers of the same brand of lenses, and were re-fit with the study lenses.
Study Type
Interventional
Enrollment (Actual)
30
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
Ohio
-
Columbus, Ohio, United States, 43210
- The Ohio State University College of Optometry
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years and older (Adult, Older Adult)
Accepts Healthy Volunteers
Yes
Genders Eligible for Study
All
Description
Inclusion Criteria:
- Must be current Acuvue® Oasys® spherical contact lens wearers.
- Distance visual acuity of 20/25 or better with current contact lenses.
- Good general health (defined by medication use that has not changed within the last month and the absence of medical conditions or treatments that are deemed confounding to the data as determined by the PI).
- Ability to give informed consent.
- Willing to spend time for the study, which includes attending two study visits and wearing contact lenses on days between study visits.
- Either gender.
- Any racial or ethnic origin.
Exclusion Criteria:
- No current ocular inflammation or infection.
- Not currently pregnant or lactating.
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: N/A
- Interventional Model: Single Group Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Experimental: All study participants
All subjects are fit into daily disposable contact lenses after wearing their optimized habitual contact lenses for ~ 1 week.
Subjects are requested to wear the lenses for two weeks, for a minimum of at least 6 hours per day for 10 days.
|
Soft, daily disposable spherical contact lens used to correct distance vision.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Contact Lens Dry Eye Questionnaire (CLDEQ-8) Survey
Time Frame: 2 weeks
|
Participants complete the Contact Lens Dry Eye Questionnaire (CLDEQ-8) survey.
This is an 8 question survey assesses symptoms while wearing contact lenses with possible scores from 0 (no symptoms) to 37 (maximum symptoms).
Higher scores indicate worsening symptoms of dry eye while wearing lenses.
|
2 weeks
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Collaborators
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
March 10, 2020
Primary Completion (Actual)
December 1, 2020
Study Completion (Actual)
December 1, 2020
Study Registration Dates
First Submitted
March 3, 2020
First Submitted That Met QC Criteria
March 3, 2020
First Posted (Actual)
March 5, 2020
Study Record Updates
Last Update Posted (Estimate)
March 7, 2023
Last Update Submitted That Met QC Criteria
March 3, 2023
Last Verified
March 1, 2023
More Information
Terms related to this study
Other Study ID Numbers
- 2020H0019
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
NO
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
Yes
product manufactured in and exported from the U.S.
Yes
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Contact Lens
-
EV Clinical TrialsCompletedContact Lens Discomfort | Contact Lens | Contact Lens DrynessUnited States
-
Southern California College of Optometry at Marshall...Ohio State University; University of Houston; Alcon Research; University of Waterloo and other collaboratorsCompletedContact Lens Complication | Contact Lens Acute Red Eye | Contact Lens Related Corneal Infiltrate (Disorder) | Contact Lens-Induced Corneal Fluorescein StainingUnited States, Canada
-
Ohio State UniversityAlcon ResearchCompleted
-
Ohio State UniversityCompletedContact LensUnited States
-
Ohio State UniversityAlcon ResearchCompleted
-
Glia, LLCCompletedContact Lens Discomfort | Contact Lens-induced Corneal Disorder | Contact Lens Acute Red Eye | Contact Lens-induced Corneal Fluorescein StainingUnited States
-
Bausch & Lomb IncorporatedCompletedContact Lens WearUnited States
-
Bausch & Lomb IncorporatedCompletedContact Lens WearUnited States
-
Bausch & Lomb IncorporatedCompletedContact Lens WearUnited States
-
Bausch & Lomb IncorporatedCompletedContact Lens WearUnited States
Clinical Trials on Daily Disposable Contact Lens
-
Coopervision, Inc.CompletedMyopiaUnited States
-
Coopervision, Inc.CORECompletedPresbyopiaUnited States, Canada
-
Coopervision, Inc.Active, not recruiting
-
Coopervision, Inc.Completed
-
Bausch & Lomb IncorporatedCompleted
-
University of ValenciaWrocław University of Science and TechnologyCompletedTear Film Hyperosmolarity
-
Coopervision, Inc.Completed
-
Jennifer FogtAlcon ResearchRecruitingPresbyopiaUnited States
-
Ohio State UniversityAlcon ResearchCompleted
-
Bausch & Lomb IncorporatedCompletedMyopia and Hyperopia and PresbyopiaUnited States